Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| U2AF1 and EZH2 mutations are associated with nonimmune hemolytic anemia in myelodysplastic syndromes. | Blood Adv | 2023 | 36129843 | PubTator, text mining | PubMed |
| Triple-negative Thrombocythemia and Subsequent Acute Lymphoblastic Leukemia with Additional Somatic Mutations. | Intern Med | 2023 | 36104197 | PubTator, text mining | PubMed |
| Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome. | Blood Adv | 2023 | 35973199 | PubTator, text mining | PubMed |
| Clinical and biological impact of ATP-binding cassette transporter activity in adult acute myeloid leukemia. | Haematologica | 2023 | 35924580 | PubTator, text mining | PubMed |
| Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2A rearrangements. | Cancer Med | 2023 | 35833755 | PubTator, text mining | PubMed |
| Unbiased decision-making for acute myeloid leukemia still needed. | Haematologica | 2023 | 35708138 | PubTator, text mining | PubMed |
| Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning. | Haematologica | 2023 | 35708137 | PubTator, text mining | PubMed |
| Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4. | Haematologica | 2023 | 35678031 | PubTator, text mining | PubMed |
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis. | Haematologica | 2023 | 35443559 | PubTator, text mining | PubMed |
| Erdheim-Chester disease after Essential Thrombocythemia: coincidence or not? | Hematol Transfus Cell Ther | 2023 | 34034993 | PubTator, text mining | PubMed |
| Advances in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia. | Blood Cell Ther | 2022 | 37220610 | PubTator, text mining | PubMed |
| A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms. | Cancer Res Commun | 2022 | 36873623 | PubTator, text mining | PubMed |
| [Clinical features and survival analysis in non-M(3) acute myeloid leukemia patients with ASXL1 gene mutation]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709197 | PubTator, text mining | PubMed |
| [Risk factors for leukemia transformation in patients with myelodysplastic syndromes]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709195 | PubTator, text mining | PubMed |
| [8p11 myeloproliferative syndrome with TRIM24/FGFR1 and FGFR1/TRIM24 fusion gene positive: a case report]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709160 | PubTator, text mining | PubMed |
| [Efficacy and safety of Venetoclax in the treatment of 25 patients with recurrent hematologic malignancies after an allogeneic hematopoietic stem cell transplantation]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709130 | PubTator, text mining | PubMed |
| [Chinese guideline for the diagnosis and treatment of polycythemia vera (2022)]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709129 | PubTator, text mining | PubMed |
| The mutation in splicing factor genes correlates with unfavorable prognosis, genomic instability, anti-tumor immunosuppression and increased immunotherapy response in pan-cancer. | Front Cell Dev Biol | 2022 | 36684432 | PubTator, text mining | PubMed |
| Concurrent Mutations in SF3B1 and PHF6 in Myeloid Neoplasms. | Biology (Basel) | 2022 | 36671709 | PubTator, text mining | PubMed |
| Hematopoietic Stem Cells (HSC) and Granulocyte Macrophage Progenitors (GMP) are the Oxidative Stress Targets in Low/Intermediate-1 Risk Myelodysplastic Syndromes. | J Biotechnol Biomed | 2022 | 36644527 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=35